Tackling Affordability with Direct-to-Patient Sales
April 11, 2025 Accessing affordable healthcare is one of the biggest challenges U.S. patients face.…
CertaraApril 11, 2025
Write Quicker PBPK Reports with the Simcyp Report Assistant
April 11, 2025 Writing a report for PBPK models can be an onerous process, especially…
CertaraApril 11, 2025
Delivering DSUR Excellence for Multinational Biopharma
A global leader in immuno-oncology approached us for support with over 50 simple to complex…
CertaraApril 11, 2025
Model-Based Meta-Analysis (MBMA) for Relative Treatment Effects and Absolute Outcomes: A Focus on Concepts and Applications
Vice President, MBMA Capability Lead, Certara Drug Development Solutions Matt advances the integration of published…
CertaraApril 10, 2025
FDA plans to phase out animal testing requirements
Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…
CertaraApril 10, 2025
How Certara MIDD Experts Overcame Client Regulatory Challenges
Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory…
CertaraApril 8, 2025
Standardizing Real World Data in Rare Disease: ATHN’s Journey
Learn how Certara helped ATHN standardize Real World Data for regulatory submissions, advancing rare disease…
CertaraApril 8, 2025
